卓正医疗更新招股书：深耕中高端医疗服务市场，今年前8个月营收约7亿元

Core Viewpoint - Zhuozheng Medical Holdings Limited is advancing its IPO process on the Hong Kong Stock Exchange, focusing on the high-end medical service market targeting affluent consumers in major Chinese cities [2]. Group 1: Company Overview - Established in 2012, Zhuozheng Medical specializes in high-end medical services, targeting affluent consumers who prefer personalized healthcare [2]. - The company operates 19 medical service institutions in China, including 17 clinics and 2 hospitals, and has additional clinics in Singapore and Malaysia [2]. Group 2: Market Position - Zhuozheng Medical ranks first in the number of cities covered and second in the number of paid patient visits among private high-end comprehensive medical service groups in China as of 2024 [2]. Group 3: Customer Satisfaction and Marketing - The company relies on patient satisfaction for marketing, with a net promoter score increasing from 81.1 in 2022 to 87.6 in the first eight months of 2024 [3][4]. - Zhuozheng Medical has a membership base of 116,542 as of August 31, 2025, with renewal rates rising from 42% in 2022 to 67% in 2024 [4]. Group 4: Financial Performance - Zhuozheng Medical's revenue grew from 473 million yuan in 2022 to 690 million yuan in 2023, reaching 959 million yuan in 2024, with 696 million yuan reported in the first eight months of 2025 [4]. - The company achieved profitability in 2024, with an adjusted net profit of approximately 10.45 million yuan in the first eight months of 2025 [5]. Group 5: Investment and Use of IPO Proceeds - Major investors include Tencent, which holds a 19.39% stake, making it the largest institutional investor [6]. - The net proceeds from the IPO will be used for developing a medical AI talent pool, upgrading existing facilities, establishing new institutions, and potential acquisitions in first-tier and new first-tier cities [6].